Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

20/20 Biolabs Inc.

Contributing Author

Recent Articles by 20/20 Biolabs Inc.

Aug-28
20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest Revenue and Expanding Commercial Opportunity AIDX GlobeNewswire
Aug-26
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest Revenue and Expanding Commercial Opportunity AIDX +6.59% GlobeNewswire
Aug-17
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level AIDX GlobeNewswire
Jul-30
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management's Recent East Asia Business Development Tour AIDX -8.49% GlobeNewswire
Jul-27
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy AIDX -8.31% GlobeNewswire
Jul-23
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock AIDX -6.76% GlobeNewswire
Jul-09
20/20 BioLabs Highlights Investor Webinar Focused on OneTest for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth AIDX GlobeNewswire
Jun-22
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month AIDX -6.85% GlobeNewswire
May-27
20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters AIDX GlobeNewswire
May-22
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand AIDX -18.67% GlobeNewswire
May-20
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress AIDX AIDX -6.59% GlobeNewswire
May-14
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 AIDX GlobeNewswire
May-12
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina AIDX +6.33% GlobeNewswire
Apr-07
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest for Cancer Through Evexia Platform AIDX -5.45% GlobeNewswire
Mar-31
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress AIDX +5.62% GlobeNewswire
Mar-27
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test AIDX GlobeNewswire
Mar-24
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program AIDX -17.59% GlobeNewswire
Mar-12
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies AIDX -8.49% GlobeNewswire
Feb-25
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities AIDX -28.82% GlobeNewswire
Feb-20
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time AIDX -38.04% GlobeNewswire
Feb-19
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth AIDX GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)